Further evaluation of the significance of urinary hydroxyproline determinations in the diagnosis of thyroid disorders

Prockop, 1967, Ann. Internal Med., 66, 1243, 10.7326/0003-4819-66-6-1243 Kivirikko, 1963, Acta Physiol. Scand., 57, 462, 10.1111/j.1748-1716.1963.tb02609.x Kivirikko, 1964, Acta Physiol. Scand., 61, 49, 10.1111/j.1748-1716.1964.tb02941.x Keiser, 1962, J. Clin. Invest., 41, 1371 Danowski, 1964, Metabolism, 13, 729, 10.1016/0026-0495(64)90018-6 Dull, 1963, New Engl. J. Med., 268, 132, 10.1056/NEJM196301172680305 Benoit, 1963, Metabolism, 12, 1072 Kivirikko, 1964, J. Clin. Endocrinol., 24, 222, 10.1210/jcem-24-2-222 Rubegni, 1964, Boll. Soc. Ital. Biol. Sper., 41, 355 Kivirikko, 1965, J. Clin. Endocrinol., 25, 1347, 10.1210/jcem-25-10-1347 Kocher, 1965, Helv. Med. Acta, 32, 480 Kivirikko, 1967, Endocrinology, 80, 1051, 10.1210/endo-80-6-1051 Kivirikko, 1965, Acta Chem. Scand., 19, 1781, 10.3891/acta.chem.scand.19-1781 Fink, 1967, J. Lab. Clin. Med., 69, 950 Phelps, 1967, Clin. Res., 15, 467 Kivirikko, 1965, Ann. Paediat. Fenniae, 11, 148 Laitinen, 1966, Acta Med. Scand., 179, 275, 10.1111/j.0954-6820.1966.tb05459.x Lamberg, 1967, Acta Endocrinol., 153, 10.1530/acta.0.056S0153 Kivirikko, 1967, Anal. Biochem., 19, 249, 10.1016/0003-2697(67)90160-1 Barker, 1951, J. Clin. Invest., 30, 55, 10.1172/JCI102416 Jacobs, 1968, Clin. Chim. Acta, 20, 113, 10.1016/0009-8981(68)90393-8 Leroy, 1967, Advan. Clin. Chem., 10, 213, 10.1016/S0065-2423(08)60114-6 Ziff, 1956, J. Clin. Invest., 35, 579, 10.1172/JCI103311 Prockop, 1961, J. Clin. Invest., 40, 843, 10.1172/JCI104318 Prockop, 1962, Lancet, ii, 527, 10.1016/S0140-6736(62)90400-2 Prockop, 1968, Vol. II, 215